129 related articles for article (PubMed ID: 6594319)
1. Influence of the peptide chain length of new elongated tuftsin analogs on phagocytosis process.
Konopińska D; Kazanowska B; Bogusławska-Jaworska J
Int J Pept Protein Res; 1984 Sep; 24(3):267-73. PubMed ID: 6594319
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological investigations of new tuftsin analogs with elongated peptide chain.
Konopinska D; Luczak M; Gumułka S
Int J Pept Protein Res; 1983 Aug; 22(2):223-30. PubMed ID: 6311764
[TBL] [Abstract][Full Text] [Related]
3. Competition between tuftsin and HBV S-protein sequences.
Siemion IZ; Słoń J; Nawrocka E; Wieczorek Z
Int J Pept Protein Res; 1990 May; 35(5):428-33. PubMed ID: 2376468
[TBL] [Abstract][Full Text] [Related]
4. Competition between tuftsin and HIV-1, HIV-2 envelope protein sequences.
Siemion IZ; Słoń J; Wieczorek Z
Arch Immunol Ther Exp (Warsz); 1991; 39(5-6):469-78. PubMed ID: 1841544
[TBL] [Abstract][Full Text] [Related]
5. Tuftsin, a natural activator of phagocytic functions including tumoricidal activity.
Najjar VA; Konopinska D; Chaudhuri MK; Schmidt DE; Linehan L
Mol Cell Biochem; 1981 Dec; 41():3-12. PubMed ID: 6895774
[TBL] [Abstract][Full Text] [Related]
6. Enhanced phagocytosis activity of cyclic analogs of tuftsin.
Nishioka K; Obeyesekere NU; McMurray JS
Biochem Pharmacol; 1995 Mar; 49(5):735-8. PubMed ID: 7887989
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and functional studies of tuftsin analogs containing isopeptide bond.
Mezö G; Szekerke M; Sármay G; Gergely J
Peptides; 1990; 11(3):405-15. PubMed ID: 2381868
[TBL] [Abstract][Full Text] [Related]
8. The analgesic activity of some tuftsin- and tuftsin inhibitor-like fragments of the viral coat proteins.
Obuchowicz E; Słoń JJ; Klin M; Madej A; Siemion IZ; Herman ZS
Pol J Pharmacol; 1993; 45(3):269-79. PubMed ID: 8220660
[TBL] [Abstract][Full Text] [Related]
9. The influence of synthetic tuftsin and its analogs on the function of granulocytes of children with acute lymphoblastic leukemia.
Kazanowska B; Steuden W; Bogusławska-Jaworska J; Konopińska D
Arch Immunol Ther Exp (Warsz); 1987; 35(2):169-73. PubMed ID: 3482149
[TBL] [Abstract][Full Text] [Related]
10. Antinociceptive action of the SP1-4 tetrapeptide and of some tuftsin analogs.
Semion IZ; Nawrocka E; Słoń J; Tartar A; Obuchowicz E; Gołba K; Herman ZS
Pol J Pharmacol Pharm; 1990; 42(4):393-401. PubMed ID: 1711198
[TBL] [Abstract][Full Text] [Related]
11. Effect of tuftsin and its partial sequences on the arterial blood pressure in guinea-pigs.
Paradowski A; Dynowski Z; Kubik A; Siemion IZ
Arch Immunol Ther Exp (Warsz); 1991; 39(1-2):147-52. PubMed ID: 1804045
[TBL] [Abstract][Full Text] [Related]
12. Tuftsin: its chemistry, biology, and clinical potential.
Fridkin M; Najjar VA
Crit Rev Biochem Mol Biol; 1989; 24(1):1-40. PubMed ID: 2667894
[TBL] [Abstract][Full Text] [Related]
13. The similarity between tuftsin (Thr-Lys-Pro-Arg) receptors and tuftsin antibody: a case of induced molecular mimicry.
Chaudhuri MK; Konopińska D; Bump NJ; Najjar VA
Ann N Y Acad Sci; 1983; 419():135-42. PubMed ID: 6324634
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological activity of tuftsin and rigin derivatives containing monosaccharides or monosaccharide derivatives.
Rocchi R; Biondi L; Cavaggion F; Filira F; Gobbo M; Dagan S; Fridkin M
Int J Pept Protein Res; 1987 Feb; 29(2):262-75. PubMed ID: 3570666
[TBL] [Abstract][Full Text] [Related]
15. Tuftsin (Thr-Lys-Pro-Arg), a natural modulator of macrophage activity: further studies.
Bump NJ; Najjar VA
Mol Cell Biochem; 1984 Sep; 63(2):137-42. PubMed ID: 6493218
[TBL] [Abstract][Full Text] [Related]
16. Molecular basis of familial and acquired phagocytosis deficiency involving the tetrapeptide, thr-lys-pro-arg, tuftsin.
Najjar VA
Exp Cell Biol; 1978; 46(1-2):114-26. PubMed ID: 579629
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological activity of [L-3,4-dehydroproline3]-tuftsin.
Amoscato AA; Babcock GF; Nishioka K
Peptides; 1984; 5(3):489-94. PubMed ID: 6548023
[TBL] [Abstract][Full Text] [Related]
18. The clinical and physiological aspects of tuftsin deficiency syndromes exhibiting defective phagocytosis.
Najjar VA
Klin Wochenschr; 1979 Aug; 57(15):751-6. PubMed ID: 385971
[TBL] [Abstract][Full Text] [Related]
19. Further investigations on the antinociceptive activity of tuftsin analogs.
Nawrocka-Bolewska E; Kubik A; Szewczuk Z; Siemion IZ; Obuchowicz E; Gołba K; Herman ZS
Pol J Pharmacol Pharm; 1991; 43(4):281-8. PubMed ID: 1811220
[TBL] [Abstract][Full Text] [Related]
20. A comparative study of [Leu1]Tuftsin and tuftsin, a natural phagocytosis-stimulating peptide.
Nishioka K; Hurr KJ; Dessens SE; Rodriguez T
Int J Biochem; 1991; 23(5-6):627-30. PubMed ID: 2065822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
